Abstract:The incidence of hepatocellular carcinoma(HCC) has increased worldwide over the past two decades.Surgical resection and liver transplantation have been demonstrated as potentially curative treatment options,which could be considered in 30% to 40% of HCC patients.Recent advancements of surgical treatment have focused not only on the surgical techniques,but also the hepatic functional reserve evaluation,resectability assessment and the effects of biological characteristics of tumor on prognosis.There is no single variable to evaluate hepatic functional reserve accurately.The combination of Child-Pugh classification,15-minute retention rate?for?Indocyanine Green(ICG15),portal vein pressure and remanent liver volume measurement is a reasonable strategy prior to Child-Pugh classification alone for liver resection.Five-year survival rate after liver resection for HCC is about 50%.The results may be acceptable for some selected patients underwent tumor resection with thrombectomy,including HCC with portal vein tumor thrombus and bile duct thrombosis.The choice of local resection or regular hepatectomy is still controversial although the former is common in HCC with cirrhosis,and the latter is in the setting without liver cirrhosis.The result of liver transplantation for HCC is better than that of liver resection,and Milan criteria is a generally accepted algorithm.Any attempts to expand the selection criteria should be cautious in the present setting of organ shortage.Salvage transplantation for intra-hepatic recurrence after liver resection may be a good choice in some resectable HCC.The recurrence and metastasis after surgical treatments are of the main obstacle to achieve better results.Identification of predictive factors could be helpful to develop prevention strategies.Due to the importance of biological characteristics in tumor recurrence and metastasis,a molecular classification to predict prognosis of HCC will lead to a more personalized medicine.Targeting key molecules of biological pathways could optimize therapeutic modality in HCC.

Current Status of Imaging Diagnosis and Treatment of Subcentimeter Hepatocellular Carcinoma

Ultrasonography of Hepatocellular Carcinoma: from Diagnosis to Prognosis

Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status

Current Opinion about Hepatocellular Carcinoma <10 mm

Subcentimeter hepatocellular carcinoma (HCC) on gadoxetic-acid-enhanced MRI: less frequent typical imaging features compared to 1–2 cm HCC but better prognosis after surgical resection

Radiomics in the Diagnosis and Treatment of Hepatocellular Carcinoma

Diagnostic imaging and interventional therapy of hepatocellular carcinoma.

[Research progress and prospects of the application of radiographic imaging in the precise diagnosis and treatment of hepatocellular carcinoma]

State-of-the-art imaging of hepatocellular carcinoma

Current Management of Hepatocellular Carcinoma.

Advanced Imaging Techniques in the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma

A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma

Endoscopic ultrasound for the diagnosis and treatment of primary hepatocellular carcinoma

Imaging in Hepatocellular Carcinoma: What's New?

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound

Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects

An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid–enhanced MRI

Advancements in the Surgical Treatment of Hepatocellular Carcinoma

On‐Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019–2022)

Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines